Partho P. Sengupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Partho P. Sengupta has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
Sirish Shrestha
West Virginia University Heart & Vascular Institute, Morgantown, West Virginia
3 shared publicationsAlaa Mabrouk Salem Omar
Division of Cardiology
2 shared publicationsBijoy K. Khandheria
University of Wisconsin School of Health
2 shared publicationsBrijesh Patel
Heart and Vascular Institute, West Virginia University, Morgantown, West Virginia, USA
2 shared publicationsJagat Narula
Icahn School of Medicine at Mount Sinai New York NY USA
2 shared publications- Karthik Seetharam
Department of Cardiovascular Surgery, Mount Sinai Medical Center, New York, NY, USA
2 shared publications
Latest Publications
- Open Access
- 1 June 2021
- Published by Elsevier in JACC: Cardiooncology
- Vol. 3 (2) , 290-293
Early Tracking of Radiation-Induced Cardiotoxicity
- 1 June 2021
- Published by Elsevier in JACC: Cardiooncology
- Vol. 3 (2) , 290-293
Open AccessEarly Tracking of Radiation-Induced Cardiotoxicity
- Open Access
Deep Neural Survival Networks for Cardiovascular Risk Prediction: The Multi-Ethnic Study of Atherosclerosis (MESA)
Background: There is growing interest in utilizing machine learning techniques for routine atherosclerotic cardiovascular disease (ASCVD) risk prediction. We investigated whether novel deep learning survival models can augment ASCVD risk prediction over existing statistical and machine learning approaches. Methods: 6,814 participants from the Multi-Ethnic Study of Atherosclerosis (MESA) were followed over 16 years to assess incidence of all-cause mortality (mortality) or a composite of major adverse events (MAE). Features were evaluated within the categories of traditional risk factors, inflammatory biomarkers, and imaging markers. Data was split into an internal training/testing (four centers) and external validation (two centers). Both machine learning (COXPH, RSF, and lSVM) and deep learning (nMTLR and DeepSurv) models were evaluated. Results: In comparison to the COXPH model, DeepSurv significantly improved ASCVD risk prediction for MAE (AUC: 0.82 vs. 0.79, P ≤0.001) and mortality (AUC: 0.86 vs. 0.80, P ≤0.001) with traditional risk factors alone. Implementing non-categorical NRI, we noted a 65% increase in correct reclassification compared to the COXPH model for both MAE and mortality ( P ≤0.05). Assessing the relative risk of participants, DeepSurv was the only learning algorithm to develop a significantly improved risk score criteria, which outcompeted COXPH for both MAE (4.07 vs. 2.66, P ≤0.001) and mortality (6.28 vs. 4.67, P =0.014). The addition of inflammatory or imaging biomarkers to traditional risk factors showed minimal/no significant improvement in model prediction. Conclusion: DeepSurv can leverage simple office-based clinical features alone to accurately predict ASCVD risk and cardiovascular outcomes, without the need for additional features, such as inflammatory and imaging biomarkers.
Open AccessDeep Neural Survival Networks for Cardiovascular Risk Prediction: The Multi-Ethnic Study of Atherosclerosis (MESA)
Background: There is growing interest in utilizing machine learning techniques for routine atherosclerotic cardiovascular disease (ASCVD) risk prediction. We investigated whether novel deep learning survival models can augment ASCVD risk prediction over existing statistical and machine learning approaches. Methods: 6,814 participants from the Multi-Ethnic Study of Atherosclerosis (MESA) were followed over 16 years to assess incidence of all-cause mortality (mortality) or a composite of major adverse events (MAE). Features were evaluated within the categories of traditional risk factors, inflammatory biomarkers, and imaging markers. Data was split into an internal training/testing (four centers) and external validation (two centers). Both machine learning (COXPH, RSF, and lSVM) and deep learning (nMTLR and DeepSurv) models were evaluated. Results: In comparison to the COXPH model, DeepSurv significantly improved ASCVD risk prediction for MAE (AUC: 0.82 vs. 0.79, P ≤0.001) and mortality (AUC: 0.86 vs. 0.80, P ≤0.001) with traditional risk factors alone. Implementing non-categorical NRI, we noted a 65% increase in correct reclassification compared to the COXPH model for both MAE and mortality ( P ≤0.05). Assessing the relative risk of participants, DeepSurv was the only learning algorithm to develop a significantly improved risk score criteria, which outcompeted COXPH for both MAE (4.07 vs. 2.66, P ≤0.001) and mortality (6.28 vs. 4.67, P =0.014). The addition of inflammatory or imaging biomarkers to traditional risk factors showed minimal/no significant improvement in model prediction. Conclusion: DeepSurv can leverage simple office-based clinical features alone to accurately predict ASCVD risk and cardiovascular outcomes, without the need for additional features, such as inflammatory and imaging biomarkers.
- 1 December 2020
- Published by Elsevier in The American Journal of Cardiology
- Vol. 136, 122-130
Usefulness of Semisupervised Machine-Learning-Based Phenogrouping to Improve Risk Assessment for Patients Undergoing Transcatheter Aortic Valve Implantation
- 1 December 2020
- Published by Elsevier in The American Journal of Cardiology
- Vol. 136, 122-130
Usefulness of Semisupervised Machine-Learning-Based Phenogrouping to Improve Risk Assessment for Patients Undergoing Transcatheter Aortic Valve Implantation
- Open Access
- 1 September 2020
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 21 (9) , 994-1004
Non-invasive prediction of tissue Doppler-derived E/e′ ratio using lung Doppler signals
Lung Doppler signals (LDS) represent the radial movement of small pulmonary blood vessel walls, caused by pulse waves of cardiac origin. We sought to investigate the accuracy and prognostic value of LDS as a predictor of mitral valve early diastolic flow to annular velocity ratio (E/e′), in patients with acute decompensated heart failure (ADHF). We prospectively enrolled patients with ADHF (n = 99, mean age 65 ± 15 years, 61% males) who underwent echocardiographic and simultaneous LDS evaluation at hospital admission. Patients with hospital stay over 72 h underwent a repeat echocardiogram and LDS assessment before discharge. Patients were followed for the occurrence of short-term all-cause mortality and heart failure (HF) hospitalization. Predicted E/e′ from LDS correlated with echocardiographic E/e′ at admission and discharge (r = 0.67 and 0.83; P < 0.001 for both), respectively. Patients were dichotomized into two groups by the median predicted-E/e′. A high predicted-E/e′ was associated with age, hypertension, anaemia, history of HF with preserved ejection fraction (EF), and chronic kidney disease. Over a median follow-up period of 7 months, 22 (22.2%) patients died and 23 (23.2%) patients were rehospitalized for HF. Kaplan–Meier analysis revealed a significantly lower event-free survival in high predicted-E/e′ group HF patients with reduced EF (P = 0.0247). No significant differences were observed in HF rehospitalization rates between the two groups. In this single-centre prospective study of patients with ADHF, LDS predicted echocardiographic E/e′ measurements and showed prognostic value in predicting all-cause mortality in HF patients with a reduced EF.
- 1 September 2020
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 21 (9) , 994-1004
Open AccessNon-invasive prediction of tissue Doppler-derived E/e′ ratio using lung Doppler signals
Lung Doppler signals (LDS) represent the radial movement of small pulmonary blood vessel walls, caused by pulse waves of cardiac origin. We sought to investigate the accuracy and prognostic value of LDS as a predictor of mitral valve early diastolic flow to annular velocity ratio (E/e′), in patients with acute decompensated heart failure (ADHF). We prospectively enrolled patients with ADHF (n = 99, mean age 65 ± 15 years, 61% males) who underwent echocardiographic and simultaneous LDS evaluation at hospital admission. Patients with hospital stay over 72 h underwent a repeat echocardiogram and LDS assessment before discharge. Patients were followed for the occurrence of short-term all-cause mortality and heart failure (HF) hospitalization. Predicted E/e′ from LDS correlated with echocardiographic E/e′ at admission and discharge (r = 0.67 and 0.83; P < 0.001 for both), respectively. Patients were dichotomized into two groups by the median predicted-E/e′. A high predicted-E/e′ was associated with age, hypertension, anaemia, history of HF with preserved ejection fraction (EF), and chronic kidney disease. Over a median follow-up period of 7 months, 22 (22.2%) patients died and 23 (23.2%) patients were rehospitalized for HF. Kaplan–Meier analysis revealed a significantly lower event-free survival in high predicted-E/e′ group HF patients with reduced EF (P = 0.0247). No significant differences were observed in HF rehospitalization rates between the two groups. In this single-centre prospective study of patients with ADHF, LDS predicted echocardiographic E/e′ measurements and showed prognostic value in predicting all-cause mortality in HF patients with a reduced EF.
- Open Access
- 1 May 2020
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 21 (5) , 511-521
Comparing sedation vs. general anaesthesia in transoesophageal echocardiography-guided percutaneous transcatheter mitral valve repair: a meta-analysis
Transoesophageal echocardiography-guided percutaneous transcatheter mitral valve repair (TOE-guided PMVR) using edge-to-edge leaflet plication is typically performed under general anaesthesia (GA). Increasing evidence supports the efficacy and safety of PMVR performed under conscious sedation (CS) or deep sedation (DS). We performed a meta-analysis comparing safety and efficacy of CS/DS vs. GA in PMVR. A comprehensive search was performed using PubMed, CINAHL, Ovid MEDLINE, Embase, and the Cochrane Library. Study characteristics, participant demographics, and procedural outcomes with both types of anaesthesia were analysed. Out of 73 articles, five met inclusion criteria. Overall, there was no significant difference in the primary outcome of procedural success rate [odds ratio (OR) 0.75; 95% confidence interval (CI) 0.30–1.88, I2= 0.0%, P = 0.538] or post-procedure in-hospital mortality (OR 1.02; 95% CI 0.38–2.71, I2= 0.0%, P = 0.970) in the patients undergoing PMVR under CS/DS vs. GA. The secondary endpoint of intensive care unit (ICU) length of stay (LOS) was significantly shorter in patients under CS/DS vs. GA (standardized mean difference, SMD = −0.97; 95% CI −1.75 to −0.20; P = 0.014), but the hospital LOS (SMD = 0.36; 95% CI −0.77 to 0.04, P = 0.078) did not show a statistically significant difference between the groups, although it was shorter in the CS/DS group. No difference was observed between CS/DS and GA in fluoroscopy time, procedure time, or complications, including pneumonia, stroke/transient ischaemic attack, and major bleeding. CS or DS has lower ICU LOS, but comparable procedural success rate and in-hospital mortality, making it a potential alternative to GA for TOE-guided PMVR.
- 1 May 2020
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 21 (5) , 511-521
Open AccessComparing sedation vs. general anaesthesia in transoesophageal echocardiography-guided percutaneous transcatheter mitral valve repair: a meta-analysis
Transoesophageal echocardiography-guided percutaneous transcatheter mitral valve repair (TOE-guided PMVR) using edge-to-edge leaflet plication is typically performed under general anaesthesia (GA). Increasing evidence supports the efficacy and safety of PMVR performed under conscious sedation (CS) or deep sedation (DS). We performed a meta-analysis comparing safety and efficacy of CS/DS vs. GA in PMVR. A comprehensive search was performed using PubMed, CINAHL, Ovid MEDLINE, Embase, and the Cochrane Library. Study characteristics, participant demographics, and procedural outcomes with both types of anaesthesia were analysed. Out of 73 articles, five met inclusion criteria. Overall, there was no significant difference in the primary outcome of procedural success rate [odds ratio (OR) 0.75; 95% confidence interval (CI) 0.30–1.88, I2= 0.0%, P = 0.538] or post-procedure in-hospital mortality (OR 1.02; 95% CI 0.38–2.71, I2= 0.0%, P = 0.970) in the patients undergoing PMVR under CS/DS vs. GA. The secondary endpoint of intensive care unit (ICU) length of stay (LOS) was significantly shorter in patients under CS/DS vs. GA (standardized mean difference, SMD = −0.97; 95% CI −1.75 to −0.20; P = 0.014), but the hospital LOS (SMD = 0.36; 95% CI −0.77 to 0.04, P = 0.078) did not show a statistically significant difference between the groups, although it was shorter in the CS/DS group. No difference was observed between CS/DS and GA in fluoroscopy time, procedure time, or complications, including pneumonia, stroke/transient ischaemic attack, and major bleeding. CS or DS has lower ICU LOS, but comparable procedural success rate and in-hospital mortality, making it a potential alternative to GA for TOE-guided PMVR.
- 1 February 2020
- Published by Taylor & Francis in Expert Review of Cardiovascular Therapy
- Vol. 18 (2) , 77-84
Machine learning for predicting cardiac events: what does the future hold?
Introduction: With the increase in the number of patients with cardiovascular diseases, better risk-prediction models for cardiovascular events are needed. Statistical-based risk-prediction models for cardiovascular events (CVEs) are available, but they lack the ability to predict individual-level risk. Machine learning (ML) methods are especially equipped to handle complex data and provide accurate risk-prediction models at the individual level. Areas covered: In this review, the authors summarize the literature comparing the performance of machine learning methods to that of traditional, statistical-based models in predicting CVEs. They provide a brief summary of ML methods and then discuss risk-prediction models for CVEs such as major adverse cardiovascular events, heart failure and arrhythmias. Expert opinion: Current evidence supports the superiority of ML methods over statistical-based models in predicting CVEs. Statistical models are applicable at the population level and are subject to overfitting, while ML methods can provide an individualized risk level for CVEs. Further prospective research on ML-guided treatments to prevent CVEs is needed.
- 1 February 2020
- Published by Taylor & Francis in Expert Review of Cardiovascular Therapy
- Vol. 18 (2) , 77-84
Machine learning for predicting cardiac events: what does the future hold?
Introduction: With the increase in the number of patients with cardiovascular diseases, better risk-prediction models for cardiovascular events are needed. Statistical-based risk-prediction models for cardiovascular events (CVEs) are available, but they lack the ability to predict individual-level risk. Machine learning (ML) methods are especially equipped to handle complex data and provide accurate risk-prediction models at the individual level. Areas covered: In this review, the authors summarize the literature comparing the performance of machine learning methods to that of traditional, statistical-based models in predicting CVEs. They provide a brief summary of ML methods and then discuss risk-prediction models for CVEs such as major adverse cardiovascular events, heart failure and arrhythmias. Expert opinion: Current evidence supports the superiority of ML methods over statistical-based models in predicting CVEs. Statistical models are applicable at the population level and are subject to overfitting, while ML methods can provide an individualized risk level for CVEs. Further prospective research on ML-guided treatments to prevent CVEs is needed.
- 21 January 2020
- Published by Springer Nature in Current Cardiovascular Imaging Reports
- Vol. 13 (2) , 1-12
Current Challenges and Recent Updates in Artificial Intelligence and Echocardiography
- 21 January 2020
- Published by Springer Nature in Current Cardiovascular Imaging Reports
- Vol. 13 (2) , 1-12
Current Challenges and Recent Updates in Artificial Intelligence and Echocardiography
- 1 October 2019
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 26 (5) , 1755-1758
Machine learning for nuclear cardiology: The way forward
- 1 October 2019
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 26 (5) , 1755-1758
Machine learning for nuclear cardiology: The way forward
- 19 March 2019
- Published by Springer Nature in Current Cardiovascular Imaging Reports
- Vol. 12 (5) , 1-6
Artificial Intelligence in Nuclear Cardiology: Adding Value to Prognostication
- 19 March 2019
- Published by Springer Nature in Current Cardiovascular Imaging Reports
- Vol. 12 (5) , 1-6
Artificial Intelligence in Nuclear Cardiology: Adding Value to Prognostication
- 27 November 2018
- Published by Springer Nature
- p. 159-173
Transesophageal Echocardiography: Principles and Application
- 27 November 2018
- Published by Springer Nature
- p. 159-173
Transesophageal Echocardiography: Principles and Application